Established in 2008, Ysios Capital manages over USD 420M through three dedicated funds in life sciences. Their focus is on investing in disruptive therapeutic products and platform technologies in the biotechnology industry. With a team of experienced professionals, they aim to support talented entrepreneurs in transforming intellectual capital and scientific knowledge into successful companies.